Philip Ranker, CPA
Chief Financial Officer
Mr. Ranker brings extensive financial expertise in the manufacturing and sale of medical devices, biotechnologies, and pharmaceuticals. This includes leading efforts to prepare for and execute financings using a variety of equity and debt structures, and developing relationships with investors, bankers, and Wall Street analysts. With over 30 years experience, he was previously the CFO at Bioness, Marina Biotech and Suneva Medical. Prior to those appointments, Philip held senior finance positions at Amylin Pharmaceuticals, Nastech Pharmaceutical, Icos and Aventis Pharma SA. He has also served on the board of directors for Marina Biotech and IMARX Therapeutics. Mr. Ranker received a Bachelor of Science degree in Accounting and graduated Summa Cum Laude from the University of Kansas, is a Certified Public Accountant and completed a Board of Director Education and Certification Program from UCLA’s Anderson School of Management.